Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit

by Marinus van Hulst, Maarten J Postma, Maartje S Jacobs, Bert Loef, Auke C Reidinga, Robert G Tieleman
Published 2020-06-01

Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands.

by Jelena Stevanović, Marjolein Pompen, Hoa H Le, Mark H Rozenbaum, Robert G Tieleman, Maarten J Postma
Published 2014-01-01

Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.

by Lisa A de Jong, Jessie Groeneveld, Jelena Stevanovic, Harrie Rila, Robert G Tieleman, Menno V Huisman, Maarten J Postma, Marinus van Hulst
Published 2019-01-01

Effects of a simple cardiac rehabilitation program on improvement of self-reported physical activity in atrial fibrillation – Data from the RACE 3 study

by Bao Oanh Nguyen, E.P.J. Petra Wijtvliet, Anne H. Hobbelt, Simone I.M. De Vries, Marcelle D. Smit, Robert G. Tieleman, Dirk Jan Van Veldhuisen, Harry J.G.M. Crijns, Isabelle C. Van Gelder, Michiel Rienstra
Published 2020-12-01

Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillatio...

by Marco Alings, Frans H Rutten, Bart van den Bemt, Ewoud J Van Dijk, Suzanne C Cannegieter, Menno V Huisman, Michiel Rienstra, Frederikus A Klok, Geert-Jan Geersing, Marc A Brouwer, Robert G Tieleman, Gordon Chu, Jaap Seelig, Emmy M Trinks-Roerdink, Anouk P van Alem, Lucas VA Boersma, Hugo ten Cate, Charles JHJ Kirchhof, Harry JGM Crijns, Isabelle C van Gelder, Joris R de Groot, Frank R den Hartog, Jonas SSG de Jong, Sylvie de Jong, Timo Lenderink, Justin G Luermans, Joan G Meeder, Ron Pisters, Peter Polak, Frans Smeets, Giovanni JM Tahapary, Luc Theunissen, Serge A Trines, Pepijn van der Voort, Martin EW Hemels
Published 2020-08-01